Flupentixol is an orally active D 1 /D 2 dopamine receptor antagonist and new PI3K inhibitor ( PI3Kα IC 50 =127 nM). Flupentixol shows anti-proliferative activity to cancer cells and induces apoptosis . Flupentixol can also be used in schizophrenia, anxiolytic and depressive research.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Dopamine Receptor | Products > Signaling Pathways > PI3K | Products > Signaling Pathways > Apoptosis
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.